We review the three genetically determined disorders of glucose transport across cell membranes. Diseases such as glucose-galactose malabsorption, Fanconi–Bickel syndrome and De Vivo disease (GLUT1 deficiency syndrome (GLUT1DS)) arise from heritable mutations in transporter-encoding genes that impair monosaccharide uptake, which becomes rate-limiting in tissues where the transpor-ters serve as the main glucose carrier systems. We focus in greater detail on De Vivo disease as a prototype of a brain energy failure syndrome, for which the greatest pathophysiological detail is known, but which presents the most therapeutic challenges. The study of these diseases illustrates fundamental aspects of energetic metabolism, while providing the basis ...
Objective To examine the genotype to phenotype connection in glucose transporter type 1 (GLUT1) defi...
Glucose transporter type I deficiency syndrome (GLUT-1 DS) is an inborn error of glucose transport c...
Glucose transporter-1 deficiency syndrome is caused by mutations in the SLC2A1 gene in the majority ...
Glucose transporter type 1 (Glut1) is the main transporter involved in the cellular uptake of glucos...
Glucose transporter type 1 deficiency syndrome (GLUT1DS) is the result of impaired glucose transport...
Glut1 deficiency syndrome (Glut1DS) is a brain energy failure syndrome caused by impaired glucose tr...
AbstractGlucose transporter type 1 deficiency syndrome (GLUT1DS) is the result of impaired glucose t...
© 2019 National Academy of Pediatric Science and Innovation. All rights reserved. The article review...
Glucose transporter 1 deficiency syndrome (GLUT1DS) is a neurometabolic disorder caused by haploins...
Cloned 20 years ago, GLUT2 is a facilitative glucose transporter in the liver, pancreas, intestine, ...
Contains fulltext : 88466.pdf (publisher's version ) (Closed access)Glucose transp...
Glucose transporter 1 deficiency syndrome (GLUT1DS) is a neurometabolic disorder caused by haploinsu...
Glucose transporter type 1 deficiency syndrome is a genetically determined, treatable, neurologic di...
Glucose transporter-1 deficiency syndrome is caused by mutations in the SLC2A1 gene in the majority ...
Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a treatable condition resulting from imp...
Objective To examine the genotype to phenotype connection in glucose transporter type 1 (GLUT1) defi...
Glucose transporter type I deficiency syndrome (GLUT-1 DS) is an inborn error of glucose transport c...
Glucose transporter-1 deficiency syndrome is caused by mutations in the SLC2A1 gene in the majority ...
Glucose transporter type 1 (Glut1) is the main transporter involved in the cellular uptake of glucos...
Glucose transporter type 1 deficiency syndrome (GLUT1DS) is the result of impaired glucose transport...
Glut1 deficiency syndrome (Glut1DS) is a brain energy failure syndrome caused by impaired glucose tr...
AbstractGlucose transporter type 1 deficiency syndrome (GLUT1DS) is the result of impaired glucose t...
© 2019 National Academy of Pediatric Science and Innovation. All rights reserved. The article review...
Glucose transporter 1 deficiency syndrome (GLUT1DS) is a neurometabolic disorder caused by haploins...
Cloned 20 years ago, GLUT2 is a facilitative glucose transporter in the liver, pancreas, intestine, ...
Contains fulltext : 88466.pdf (publisher's version ) (Closed access)Glucose transp...
Glucose transporter 1 deficiency syndrome (GLUT1DS) is a neurometabolic disorder caused by haploinsu...
Glucose transporter type 1 deficiency syndrome is a genetically determined, treatable, neurologic di...
Glucose transporter-1 deficiency syndrome is caused by mutations in the SLC2A1 gene in the majority ...
Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a treatable condition resulting from imp...
Objective To examine the genotype to phenotype connection in glucose transporter type 1 (GLUT1) defi...
Glucose transporter type I deficiency syndrome (GLUT-1 DS) is an inborn error of glucose transport c...
Glucose transporter-1 deficiency syndrome is caused by mutations in the SLC2A1 gene in the majority ...